Elanco Animal Health Engages Stakeholders at Key Investor Conferences
- Elanco Animal Health engages stakeholders through prominent investor conferences, showcasing its strategic initiatives and vision for animal health.
- CFO Todd Young and CEO Jeff Simmons will participate in upcoming fireside chats at key industry events.
- Elanco’s commitment to innovation and sustainability is reflected in its mission to enhance animal health and well-being.
Elanco Animal Health Engages Stakeholders Through Investor Conferences
Elanco Animal Health Incorporated demonstrates its proactive approach in stakeholder engagement by announcing participation in a series of prominent investor conferences. These events are critical for the company, as they provide platforms for leadership to discuss strategic initiatives and the company's vision for the future of animal health. On February 27, Todd Young, the executive vice president and CFO, is set to engage in a fireside chat at the Bank of America 2025 Animal Health Summit at 12:30 p.m. ET, where he will likely address financial strategies and ongoing innovations in the animal health sector. This commitment to dialogue underscores Elanco's dedication to transparency and responsiveness to the needs of its investors and partners.
Following the Bank of America summit, Elanco's president and CEO, Jeff Simmons, will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on March 3 at 3:10 p.m. ET. This event will provide an opportunity for Simmons to share insights on Elanco’s strategic direction, including its efforts to enhance animal health and welfare through innovative solutions. Additionally, Todd Young will return to the spotlight during the Barclays 27th Annual Global Healthcare Conference on March 11 at 9:00 a.m. ET, further emphasizing Elanco's commitment to maintaining open lines of communication with stakeholders. For those interested in these discussions, audio webcasts will be available on Elanco's investor website, ensuring accessibility for a wider audience.
Elanco’s rich history, spanning nearly 70 years, positions it as a leader in the animal health industry, dedicated to preventing and treating diseases in both farm animals and pets. The company's mission revolves around enhancing the health and well-being of animals, thereby creating value for farmers, pet owners, veterinarians, and society as a whole. Elanco’s vision, encapsulated in its mantra "Food and Companionship Enriching Life," aligns closely with its commitment to sustainability and improving the lives of animals and their caretakers. This dedication is reflected in its Elanco Healthy Purpose initiative, which aims to advance the health of animals, people, and the planet.
In addition to these conferences, Elanco continues to emphasize its innovative spirit and commitment to animal health. The company’s participation in these key industry events signals its ongoing efforts to remain at the forefront of the animal health sector, contributing to advancements that benefit not only its stakeholders but also the wider community. Interested parties can stay informed about Elanco’s initiatives and updates through its official website at www.elanco.com.